Literature DB >> 16129735

Nicotinic cholinergic receptors in the rat retina: simple and mixed heteromeric subtypes.

Andrea M Marritt1, Brandon C Cox, Robert P Yasuda, J Michael McIntosh, Yingxian Xiao, Barry B Wolfe, Kenneth J Kellar.   

Abstract

Neuronal nicotinic acetylcholine receptors (nAChRs) were measured in the rat retina to determine the heteromeric subtypes. We detected seven nicotinic receptor subunit mRNA transcripts, alpha2-alpha4, alpha6, and beta2-beta4, with RNase protection assays. The density of heteromeric nAChR binding sites is approximately 3 times higher in the retina than in the cerebral cortex. Moreover, the density of the sites in the retina measured with [3H]epibatidine ([3H]EB) is approximately 30% higher than with 125I-3-(2(S)-azetidinylmethoxy)pyridine (A-85380) and more than twice that measured with [3H]cytisine or [3H](-)nicotine. These data suggest that the retina expresses multiple subtypes of nAChRs, including a large fraction of receptors containing the beta2 subunit and a smaller fraction containing the beta4 subunit. Consistent with this, in binding competition studies, nicotinic ligands fit a model for two affinity classes of binding sites, with the higher affinity sites representing 70 to 80% of the nAChRs in the retina. To determine the specific subtypes of nAChRs in the rat retina, we used subunit-specific antibodies in immunoprecipitation assays. Immunoprecipitation of [3H]EB-labeled nAChRs with antibodies specific to the beta2 and beta4 subunits indicated that approximately 80% of the receptors contained beta2 subunits and approximately 25% contained beta4 receptors, consistent with the binding pharmacology results. Sequential immunoprecipitation assays indicated that the rat retina contains multiple subtypes of nAChRs. The majority of the receptors measured seemed to be simple heteromeric subtypes, composed of a single type of alpha and a single type of beta subunit; but a significant fraction are mixed heteromeric subtypes, composed of two or more alpha and/or beta subunits.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16129735     DOI: 10.1124/mol.105.012369

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  23 in total

1.  The effects of nicotine on the human electroretinogram.

Authors:  Stefanie B Varghese; Jamie C Reid; E Eugenie Hartmann; Kent T Keyser
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-12-09       Impact factor: 4.799

2.  Positional scanning mutagenesis of α-conotoxin PeIA identifies critical residues that confer potency and selectivity for α6/α3β2β3 and α3β2 nicotinic acetylcholine receptors.

Authors:  Arik J Hone; Miguel Ruiz; Mick'l Scadden; Sean Christensen; Joanna Gajewiak; Layla Azam; J Michael McIntosh
Journal:  J Biol Chem       Date:  2013-07-11       Impact factor: 5.157

3.  Effects of chronic nicotine on heteromeric neuronal nicotinic receptors in rat primary cultured neurons.

Authors:  Ermelinda Lomazzo; Gregory P Hussmann; Barry B Wolfe; Robert P Yasuda; David C Perry; Kenneth J Kellar
Journal:  J Neurochem       Date:  2011-09-01       Impact factor: 5.372

4.  α-Conotoxin PeIA[S9H,V10A,E14N] potently and selectively blocks α6β2β3 versus α6β4 nicotinic acetylcholine receptors.

Authors:  Arik J Hone; Mick'l Scadden; Joanna Gajewiak; Sean Christensen; Jon Lindstrom; J Michael McIntosh
Journal:  Mol Pharmacol       Date:  2012-08-22       Impact factor: 4.436

5.  Cerebellar nicotinic cholinergic receptors are intrinsic to the cerebellum: implications for diverse functional roles.

Authors:  Jill R Turner; Pavel I Ortinski; Rachel M Sherrard; Kenneth J Kellar
Journal:  Cerebellum       Date:  2011-12       Impact factor: 3.847

6.  An autoradiographic survey of mouse brain nicotinic acetylcholine receptors defined by null mutants.

Authors:  Christopher G Baddick; Michael J Marks
Journal:  Biochem Pharmacol       Date:  2011-05-10       Impact factor: 5.858

7.  PeIA-5466: A Novel Peptide Antagonist Containing Non-natural Amino Acids That Selectively Targets α3β2 Nicotinic Acetylcholine Receptors.

Authors:  Arik J Hone; Fernando Fisher; Sean Christensen; Joanna Gajewiak; David Larkin; Paul Whiteaker; J Michael McIntosh
Journal:  J Med Chem       Date:  2019-06-27       Impact factor: 7.446

8.  α-Conotoxin BuIA[T5A;P6O]: a novel ligand that discriminates between α6ß4 and α6ß2 nicotinic acetylcholine receptors and blocks nicotine-stimulated norepinephrine release.

Authors:  Layla Azam; Uwe Maskos; Jean-Pierre Changeux; Cheryl D Dowell; Sean Christensen; Mariella De Biasi; J Michael McIntosh
Journal:  FASEB J       Date:  2010-08-25       Impact factor: 5.191

9.  Effects of glaucoma on Chrna6 expression in the retina.

Authors:  Gustavo C Munguba; Eldon E Geisert; Robert W Williams; Mary L Tapia; Daisy K Lam; Sanjoy K Bhattacharya; Richard K Lee
Journal:  Curr Eye Res       Date:  2012-09-24       Impact factor: 2.424

10.  Neuroprotection of rat retinal ganglion cells mediated through alpha7 nicotinic acetylcholine receptors.

Authors:  K Iwamoto; D Mata; D M Linn; C L Linn
Journal:  Neuroscience       Date:  2013-02-10       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.